QA: Citius Pharmaceuticals Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001506251_2021_Citius_Pharmaceuticals_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001506251, Citius Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 13,981,985
1 IntangibleAssetsNetIncludingGoodwill 9,346,796
2 PropertyPlantAndEquipmentNet 1,577
3 remainder_Assets 20,443,297
4 LiabilitiesCurrent 4,097,133
5 LiabilitiesNoncurrent 855,471
6 remainder_Liabilities 5,150,383
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,311,905
9 ResearchAndDevelopmentExpense 9,109,060
10 remainder_Expenses 814,316
11 remainder_Revenues 0
12 remainder_NetIncome 203,276
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 43,773,655
1 Liabilities 10,102,987
2 Expenses 21,235,281
3 Revenues 0
4 StockholdersEquity 33,670,668
5 NetIncome -21,032,005
6 ComprehensiveNetIncome -21,032,005
7 BaseVar 37,657,600
8 EconomicCapitalRatiobeforeLimitedLiability 1.94
9 EconomicCapitalRatio 2.99

Edgar->Model Mapping

Feature Distribution

Change over Time